2014. B5H7, a Morpholine Derivative of 23-Hydroxybetulinic Acid, Reverses Doxorubicin Resistance in HepG2/ADM. Journal of Cancer Research Updates. 3, 1 (Jan. 2014),  59–66. DOI:https://doi.org/10.6000/1929-2279.2014.03.01.6.